159 related articles for article (PubMed ID: 37478874)
1. Use of a common spreadsheet program to demonstrate the ability of Bayesian forecasting to estimate the pharmacokinetic parameters of antibiotics.
Brocks DR; Wang M
J Pharm Pharmacol; 2023 Oct; 75(10):1378-1387. PubMed ID: 37478874
[TBL] [Abstract][Full Text] [Related]
2. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG
Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of predicting the vancomycin concentration in Japanese cancer patients by the Sawchuk-Zaske method or Bayesian method.
Nakashima T; Ohno T; Koido K; Hashimoto H; Terakado H
J Oncol Pharm Pract; 2020 Apr; 26(3):543-548. PubMed ID: 31142231
[TBL] [Abstract][Full Text] [Related]
4. Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients.
Polard E; Le Bouquin V; Le Corre P; Kérebel C; Trout H; Feuillu A; Le Verge R; Mallédant Y
Ther Drug Monit; 1999 Aug; 21(4):395-403. PubMed ID: 10442692
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of aminoglycoside pharmacokinetics in postpartum patients using Bayesian forecasting.
Cropp CD; Davis GA; Ensom MH
Ther Drug Monit; 1998 Feb; 20(1):68-72. PubMed ID: 9485558
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin pharmacokinetics and Bayesian estimation in pediatric patients.
Wrishko RE; Levine M; Khoo D; Abbott P; Hamilton D
Ther Drug Monit; 2000 Oct; 22(5):522-31. PubMed ID: 11034256
[TBL] [Abstract][Full Text] [Related]
7. Bayesian estimation of pharmacokinetic parameters: an important component to include in the teaching of clinical pharmacokinetics and therapeutic drug monitoring.
Brocks DR; Hamdy DA
Res Pharm Sci; 2020 Dec; 15(6):503-514. PubMed ID: 33828594
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a two-compartment Bayesian forecasting program for predicting vancomycin concentrations.
Rodvold KA; Pryka RD; Garrison M; Rotschafer JC
Ther Drug Monit; 1989; 11(3):269-75. PubMed ID: 2728085
[TBL] [Abstract][Full Text] [Related]
9. Systematic external evaluation of reported population pharmacokinetic models of vancomycin in Chinese children and adolescents.
Lv C; Lu J; Jing L; Liu TT; Chen M; Zhang R; Li C; Zhou S; Wei Y; Chen Y
J Clin Pharm Ther; 2021 Jun; 46(3):820-831. PubMed ID: 33751618
[TBL] [Abstract][Full Text] [Related]
10. Optimizing Predictive Performance of Bayesian Forecasting for Vancomycin Concentration in Intensive Care Patients.
Guo T; van Hest RM; Zwep LB; Roggeveen LF; Fleuren LM; Bosman RJ; van der Voort PHJ; Girbes ARJ; Mathot RAA; Elbers PWG; van Hasselt JGC
Pharm Res; 2020 Aug; 37(9):171. PubMed ID: 32830297
[TBL] [Abstract][Full Text] [Related]
11. Bayesian method application: Integrating mathematical modeling into clinical pharmacy through vancomycin therapeutic monitoring.
Chen A; Gupta A; Do DH; Nazer LH
Pharmacol Res Perspect; 2022 Dec; 10(6):e01026. PubMed ID: 36398492
[TBL] [Abstract][Full Text] [Related]
12. A Bayesian formulation of the Kalman filter applied to the estimation of individual pharmacokinetic parameters.
Botsman K; Tickle K; Smith JD
Comput Biomed Res; 1997 Apr; 30(2):83-94. PubMed ID: 9167082
[TBL] [Abstract][Full Text] [Related]
13. Prediction of gentamicin concentrations in neonates and infants using a Bayesian pharmacokinetic model.
Rodvold KA; Gentry CA; Plank GS; Kraus DM; Nickel E; Gross JR
Dev Pharmacol Ther; 1993; 20(3-4):211-9. PubMed ID: 7828456
[TBL] [Abstract][Full Text] [Related]
14. Bayesian Vancomycin Model Selection for Therapeutic Drug Monitoring in Neonates.
Alrahahleh D; Thoma Y; Van Daele R; Nguyen T; Halena S; Luig M; Stocker S; Kim HY; Alffenaar JW
Clin Pharmacokinet; 2024 Mar; 63(3):367-380. PubMed ID: 38416322
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model-informed precision dosing trial simulations.
Aljutayli A; Thirion DJG; Bonnefois G; Nekka F
Clin Transl Sci; 2022 Apr; 15(4):942-953. PubMed ID: 35170243
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic modelling and Bayesian estimation-assisted decision tools to optimize vancomycin dosage in neonates: only one piece of the puzzle.
Allegaert K; Flint R; Smits A
Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):735-749. PubMed ID: 31402708
[No Abstract] [Full Text] [Related]
17. Bayesian forecasting of serum vancomycin concentrations in neonates and infants.
Rodvold KA; Gentry CA; Plank GS; Kraus DM; Nickel E; Gross JR
Ther Drug Monit; 1995 Jun; 17(3):239-46. PubMed ID: 7624919
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetic parameters of vancomycin in critically ill patients.
Llopis-Salvia P; Jiménez-Torres NV
J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
[TBL] [Abstract][Full Text] [Related]
19. Bayesian forecasting of serum gentamicin concentrations in intensive care patients.
Rodvold KA; Pryka RD; Kuehl PG; Blum RA; Donahue P
Clin Pharmacokinet; 1990 May; 18(5):409-18. PubMed ID: 2335046
[TBL] [Abstract][Full Text] [Related]
20. [Individualized monitoring of the therapy with gentamycin using pharmacokinetic methods. Which method to choose?].
Carvalho A; Fonseca C; Falcão F; Pereira TA; Freitas O; Parrinha A; Costa M; Rodrigues MJ; Ceia F; Luís AS
Acta Med Port; 1996; 9(7-9):187-95. PubMed ID: 9005695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]